| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.08 |